Invivyd启动COVID预防抗体VYD2311的三期临床试验

康涅狄格州纽黑文 - Invivyd, Inc. (NASDAQ:IVVD) 周二宣布启动DECLARATION试验，以评估用于COVID-19预防的候选单克隆抗体VYD2311。这家生物技术公司目前市值约6.71亿美元，其股票今年以来已上涨超过550%，因为投资者看好其COVID-19预防管线。
China.org.cn

1st LD Writethru: Yemen's STC declares 2-yr transitional phase ahead of referendum

ADEN, Yemen, Jan. 2 (Xinhua) -- Chief of Yemen's Southern Transitional Council (STC) Aidarous Al-Zubaidi announced here on Friday the launch of a two-year transitional period during which the council ...